Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may hinder progress toward equitable health care, impacting workforce diversity, ...
Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...
A major trial aiming to transform breast cancer screening with artificial intelligence (AI) has been launched, with almost 700,000 women expected to take part, the Government has announced. It is ...
An interview with Glenn Saxe, computational psychiatrist, on the limitations of our current diagnostic system, and how causal ...
Dubai World Trade Centre DWTC has announced its action-packed February events calendar featuring 12 high profile events at ...
Data supplied by Morningstar and accurate on Jul 31, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...
“Here we describe a potential biomarker, which can be readily translated into clinical practice, to improve assessment of patients with IBD and early signs of cancer to help with the decision for ...
As a result of these disruptions, NIH staff has reported being unable to meet with study participants or recruit patients into clinical trials, delays submitting research findings to science journals, ...
Thank you for signing up! Did you know with a Digital Subscription to Sunderland Echo, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ...
Thank you for signing up! Did you know with a Digital Subscription to Sunderland Echo, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ...